Re-entry circuit in ventricular tachycardia due to focal fatty-fibrosis in a patient with myotonic dystrophy

Internal Medicine

Volumn 44, Issue 2, 2005, Pages 129-135

  Muraoka, Hideyuki ^a   Negoro, Nobuyuki ^a   Terasaki, Fumio ^a   Nakakoji, Takahiro ^a   Kojima, Shigeyuki ^a   Hoshiga, Masaaki ^a   Sugino, Masakazu ^a   Hosokawa, Takafumi ^a   Ishihara, Tadashi ^a   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Catheter ablation; Endomyocardial biopsy; Fatty fibrosis; Myotonic dystrophy; Ventricular tachycardia

Indexed keywords

MYOTONIC DYSTROPHY PROTEIN KINASE;

AGED; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; CLINICAL FEATURE; CLINICAL OBSERVATION; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE PREDISPOSITION; DNA DETERMINATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART CATHETERIZATION; HEART FUNCTION TEST; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE BIOPSY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE TACHYCARDIA; HEART VENTRICULOGRAPHY; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; MALE; MYOTONIC DYSTROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; QRS COMPLEX; RADIOFREQUENCY ABLATION; REENTRY TACHYCARDIA; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TRINUCLEOTIDE REPEAT;

ADIPOSE TISSUE; AGED; BIOPSY; CARDIOMYOPATHIES; CATHETER ABLATION; DIAGNOSIS, DIFFERENTIAL; DNA; ELECTROCARDIOGRAPHY; FIBROSIS; HEART RATE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MYOTONIC DYSTROPHY; PROTEIN-SERINE-THREONINE KINASES; RADIONUCLIDE VENTRICULOGRAPHY; TACHYCARDIA, VENTRICULAR;

EID: 20144377819     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.129     Document Type: Article

References (25)

1. Buxton J, Shelbourne P, Davies J, et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355: 547-548, 1992.
2. Harley HG, Brook JD, Rundle SA, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355: 545-546, 1992.
3. Brook JD, McCurrach ME, Harley HG, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′end of a transcript encoding a protein kinase family member. Cell 69: 385, 1992.
4. Fu Y-H, Pizzuti A, Fenwick RG Jr, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255 1256-1258, 1992.
5. Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255: 1253-1255, 1992.
6. Harper PS. Myotonic Dystrophy, 3rd edition. WB Saunders, London, 2000.
7. Church SC. The heart in myotonia atrophica. Arch Intern Med 119: 176-181, 1967.
8. Fisch C. The heart in dystrophia myotonica. Am Heart J 41 525-538, 1950.
9. Motta J, Guilleminault C, Billingham M, Barry W, Mason J. Cardiac abnormalities in myotonic dystrophy: electrophysiologic and histopathologic studies. Am J Med 67: 467-473, 1979.
10. Cannom DS, Wyman MG, Goldreyer BN. Clinical and induced ventricular tachycardia in a patient with myotonic dystrophy. J Am Coll Cardiol 4: 625-628, 1984.
11. Grigg LE, Chan W, Mond HG, Vohra JK, Downey WF. Ventricular tachycardia and sudden death in myotonic dystrophy: clinical, electrophysiologic and pathologic features. J Am Coll Cardiol 6: 254-256, 1985.
12. Hiromasa S, Ikeda T, Kubota K, et al. Ventricular tachycardia and sudden death in myotonic dystrophy. Am Heart J 115: 914-915, 1988.
13. Merino JL, Carmona JR, Fernandez-Lozano I, Peinado R, Basterra N, Sobrino JA. Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation. Circulation 98: 541-546, 1998.
14. Stevenson WG, Sweeney MO. Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure. Curr Opin Cardiol 12: 242-250, 1997.
15. Nguyen HH, Wolfe JT III, Holmes DR Jr, Edwards WD. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol 11: 662-671, 1988.
16. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res 33: 13-22, 1997.
17. Vignaux O, Lazarus A, Varin J, et al. Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiologic test findings: initial results. Radiology 224: 231-235, 2002.
18. Jaspert A, Fahsold R, Grehl H, Claus D. Myotonic dystrophy: correlation of clinical symptoms with the size of the CTG trinucleotide repeat. J Neurol 242: 99-104, 1995.
19. Hayashi Y, Ikeda U, Kojo T, et al. Cardiac abnormalities and cytosine-thymine-guanine trinucleotide repeats in myotonic dystrophy. Am Heart J 134: 292-297, 1997.
20. Tokgozoglu LS, Ashizawa T, Pacifico A, Armstrong RM, Epstein HF, Zoghbi WA. Cardiac involvement in a large kindred with myotonic dystrophy: quantitative assessment and relation to size of CTG repeat expansion. JAMA 274: 813-819, 1995.
21. Lazarus A, Varin J, Ounnoughene Z, et al. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 99: 1041-1046, 1999.
22. Abbruzzese C, Costanzi Porrini S, Mariani B, et al. Instability of a permutation allele in homozygous patients with myotonic dystrophy type 1. Ann Neurol 52: 435-441, 2002.
23. Martorell L, Monckton DG, Gamez J, Baiget M. Complex patterns of male germline instability and somatic mosaicism in myotonic dystrophy type 1. Eur J Hum Genet 8: 423-430, 2000.
24. Shiraishi H, Shirayama T, Inoue K, et al. Successful catheter ablation against ventricular tachycardia associated with myotonic dystrophy. Intern Med 39: 39-44, 2000.
25. Wen MS, Yeh SJ, Wang CC, Lin FC, Chen IC, Wu D. Radiofrequency ablation therapy in idiopathic left ventricular tachycardia with no obvious structural heart disease. Circulation 89 1690-1696, 1994.